Microvascular brain pathology and late-life motor impairment

Aron S Buchman1, Lei Yu, Patricia A Boyle

  • 1Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA. Aron_S_Buchman@rush.edu

Neurology
|February 1, 2013
PubMed
Abstract

Insights

Microvascular brain pathology is common in older adults and linked to late-life motor impairment. These conditions may be an independent cause of reduced motor function in aging individuals.

Area of Science:

  • Neurology
  • Gerontology
  • Pathology

Background:

  • Microvascular brain pathology is prevalent in aging populations.
  • Its association with motor impairment in late life requires further investigation.

Purpose of the Study:

  • To investigate the link between microvascular brain pathology and motor function decline in older adults.
  • To determine if microvascular pathology is an independent predictor of late-life motor impairment.

Main Methods:

  • Utilized data from over 2,500 participants in the Religious Orders Study and Memory and Aging Project.
  • Conducted annual motor assessments and postmortem brain analysis of 850 participants for microvascular pathologies (microinfarcts, cerebral amyloid angiopathy, arteriolosclerosis).

Main Results:

  • Over 60% of participants showed evidence of at least one microvascular pathology.
  • Microinfarcts and arteriolosclerosis were significantly associated with poorer motor function, independent of other factors.
  • Arteriolosclerosis and macroinfarcts independently predicted motor function when analyzed together.

Conclusions:

  • Microvascular brain pathology is a common finding in older adults.
  • It may represent an under-recognized, independent contributor to motor impairment in later life.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...